Iovance Biotherapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update

Go back to Iovance Biotherapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update
(NASDAQ: IOVA) Delayed: 8.70 --0 (-0%)
Previous Close $8.70    52 Week High
Open $8.70    52 Week Low
Day High $8.70    P/E N/A 
Day Low $8.70    EPS
Volume 2,195